REQUEST A DEMO
Total
USD $0.00
Search more companies

AKACIA PHARMA Kft. (Hungary)

Main Activities: Management, Scientific, and Technical Consulting Services
Full name: AKACIA PHARMA Kft. Profile Updated: September 26, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English & Hungarian Download a sample report

AKACIA PHARMA Kft. is an enterprise in Hungary, with the main office in Budapest. The company operates in the Management, Scientific, and Technical Consulting Services industry. It was first established on January 29, 2007. AKACIA PHARMA Kft. currently employs 2 (2023) people. There was a net sales revenue increase of 4.37% reported in AKACIA PHARMA Kft.’s latest financial highlights for 2024. Its total assets decreased by 5% over the same period. The net profit margin of AKACIA PHARMA Kft. increased by 5.1% in 2024.

Headquarters
Kiralyhago utca 84.
Budapest; Budapest; Postal Code: 1182

Contact Details: Purchase the AKACIA PHARMA Kft. report to view the information.

Website: http://www.akacia.hu

Basic Information
Total Employees:
Purchase the AKACIA PHARMA Kft. report to view the information.
Registered Capital:
Purchase the AKACIA PHARMA Kft. report to view the information.
Financial Auditors:
Purchase the AKACIA PHARMA Kft. report to view the information.
Incorporation Date:
January 29, 2007
Key Executives
Purchase this report to view the information.
Managing Director
Ownership Details
Purchase this report to view the information.
Company Performance
Financial values in the chart are available after AKACIA PHARMA Kft. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency HUF. Absolute financial data is included in the purchased report.
Net sales revenue
4.37%
Total operating revenue
4.37%
Operating profit (EBIT)
27.16%
EBITDA
27.04%
Net Profit (Loss) for the Period
25.87%
Total Assets
-5%
Total Equity
18.95%
Operating Profit Margin (ROS)
5.8%
Net Profit Margin
5.1%
Return on Equity (ROE)
3.65%
Quick Ratio
0.56%
Cash Ratio
0.39%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?